On May 17, shares in the FFW Corp. company were selling at $40.
FFW Corp. employs 53 people and has reported $5,880,000 in income as of May 17.
In the fluctuating stock market, healthcare and technology stocks are viewed as the safest bets for long-term gains.
Besty Kuekcer with Benzinga.com said healthcare-related stocks, such as hospital conglomerates and insurance companies, have weathered numerous economic crises and still make a profit, meaning they’re a stable investment.
While technology stocks can be more risky, given the boom-bust nature of new tech companies, Kuecker recommended a diverse portfolio of tech companies to strike it big when companies succeed or sell to other larger companies.
For short-term investments, Kuecker recommended “consumer discretionary” stocks, which are sensitive to economic changes but can rise greatly on the back of a strong economy.
Nothing in this article is to be assumed as financial advice.
Individual companies can have several different types of shares across many stock markets. It is possible for different types of shares to see different results on the market.
Company Name | % of Change in Last Year | Selling Price |
---|---|---|
Bravo Multinational Inc. | 1,158.06% | $0.39 |
Bellerophon Therapeutics Inc. | 996.46% | $10.57 |
Ameritek Ventures Inc | 760% | $0.0129 |
Digital Brand Media & Marketing Group Inc. | 682.05% | $0.0061 |
Cabaletta Bio Inc. | 545.21% | $12.13 |
Biomea Fusion Inc. | 530.08% | $32.89 |
89Bio Inc. | 514.63% | $17.64 |
Ardelyx Inc. | 466.28% | $3.93 |
Arcellx Inc | 449.13% | $41.24 |
Atlas Lithium Corp | 402.22% | $22.6 |
Akero Therapeutics Inc. | 392.45% | $46.29 |
Cymabay Therapeutics Inc. | 382.37% | $9.17 |
Blue Dolphin Energy Co. | 327.59% | $3.1 |
Enliven Therapeutics Inc | 296.83% | $20 |
Clearone Inc. | 287.87% | $2.23 |
Elf Beauty Inc. | 280.34% | $90.14 |
Aldeyra Therapeutics Inc. | 273.11% | $9.85 |
Aldeyra Therapeutics Inc. | 273.11% | $9.85 |
Harrow Health Inc. | 263.6% | $20.98 |
Aehr Test Systems | 256.67% | $29.96 |
Findit Inc. | 253.57% | $0.0495 |
GlycoMimetics Inc. | 224.84% | $2.04 |
Groove Botanicals Inc | 221.21% | $0.106 |
Amylyx Pharmaceuticals Inc | 216.51% | $27.79 |
Akebia Therapeutics Inc | 206.23% | $1.13 |
Corvus Pharmaceuticals Inc. | 205.66% | $3.24 |
Astria Therapeutics Inc. | 198.55% | $12.36 |
Hims & Hers Health Inc. | 187.26% | $10.6 |
Array Technologies Inc. | 186.73% | $22.68 |
Applied Digital Corp | 182% | $7.05 |
Cidara Therapeutics Inc | 179.56% | $1.35 |
Muscle Maker Inc. | 175.46% | $1.15 |
Bel Fuse Inc. | 173.12% | $46.24 |
Bel Fuse Inc. | 173.12% | $46.24 |
BrightRock Gold Corp. | 173.09% | $0.3968 |
Fluence Energy Inc. | 172.74% | $23.51 |
Cogent Biosciences Inc. | 169.81% | $11.17 |
Accustem Sciences Ltd | 165.45% | $1.46 |
EMagin Corp. | 156.41% | $2 |
Apptech Corp. | 155.48% | $1.76 |
Heritage Global Inc. | 152.1% | $3 |
Eline Entertainment Group Inc | 150% | $0.0005 |
BioVie Inc. | 149.31% | $7.18 |
Cannabis Suisse Corp. | 148.76% | $0.05 |
Assertio Holdings Inc. | 141.02% | $7.11 |
Cadiz Inc. | 136.17% | $4.44 |
CVRx Inc. | 135.71% | $12.54 |
Axsome Therapeutics Inc. | 133.74% | $78.49 |
Vita Coco Company Inc. | 132.7% | $24.69 |
Axcelis Technologies Inc. | 127.36% | $137.69 |